natgillin/translations-raw huggingface dataset:
V ta namen se bosta največje dopolnjevanje in sinergija dosegala z drugimi programi in ukrepi Skupnosti ter z nacionalnimi in regionalnimi raziskovalnimi programi v različnih državah članicah.
To this end, the utmost complementarity and synergy will be sought with other Community programmes and actions and with national and regional research programmes in the various Member States.
Po potrebi
in research
Načelo enakosti spolov
Gender aspects will be
Razen tega nekatere bolezni prizadenejo samo ženske ali samo moške ali so pri enih oziroma drugih bolj razširjene (tak primer je fibromialgija/sindrom kronične utrujenosti, ki prizadene veliko več žensk kot moških).
Furthermore, there are diseases which affect only, or are more prevalent in, women or men (one such example is fibromyalgia/chronic fatigue syndrome, which affects far greater numbers of women than men).
Zato bi bilo treba vsem dejavnostim, ki bodo financirane v zvezi s to temo, omogočiti razlikovanje v povezanih raziskovalnih protokolih, metodologijah in analizah ugotovitev.
All the activities to be financed in connection with this theme should therefore allow for the possibility of differentiation in the related research protocols, methodologies, and analyses of results.
Sprememba 47 Priloga I, del "Teme", oddelek 1 ("Zdravje"), pododdelek "Dejavnosti", naslov 1 ("Biotehnologija, generična orodja in tehnologije za človekovo zdravje"), alinea 1 –
Amendment 47 Annex I, part 'Themes', section 1 ('Health'), subsection 'Activities', first heading ('Biotechnology, generic tools and technologies for human health'), indent 1 -
Zahtevne proizvodne raziskave: razvoj novih raziskovalnih orodij za moderno biologijo, ki bodo znatno pospešila postopek priprave podatkov ter izboljšala standardizacijo, pridobivanje in analiziranje podatkov in vzorcev (biobanke).
High-throughput research: to develop new research tools for modern biology that will enhance significantly data generation and improve data and specimen (biobanks) standardisation, acquisition and analysis.
Zahtevne proizvodne raziskave: razvoj novih raziskovalnih orodij za moderno biologijo, ki bodo znatno pospešila postopek priprave podatkov ter izboljšala standardizacijo, pridobivanje in
High-throughput research: to develop new research tools for modern biology that will enhance significantly data generation and improve data and specimen (biobanks) standardisation, acquisition and
poskusno ter bioračunalniško
experimental and biocomputational
Poudarek bo na novih tehnologijah za: zaporedje
The focus will be on new technologies for: sequencing
s hitrimi, gospodarnimi in široko dostopnimi metodami
using rapid, economic and widely available methods
, izražanje genov, genotipizacijo in fenotipizacijo; izražanje genov, genotipizacijo in fenotipizacijo; strukturno genomiko; bioinformatiko in sistemsko biologijo,
; gene expression, genotyping and phenotyping; structural genomics; bioinformatics and systems biology
vključno s superračunalništvom za strukturno modeliranje
, including super computing for structural modelling
Sprememba 172 Priloga I, del "Teme", oddelek 1 ("Zdravje"), pododdelek "Dejavnosti", naslov 1 ("Biotehnologija, generična orodja in tehnologije za človekovo zdravje"), alinea 2
Amendment 172 Annex I, part 'Themes', section 1 ('Health'), subsection 'Activities', heading 1 ('Biotechnology, generic tools and technologies for human health'), indent 2
Odkrivanje, diagnoza in spremljanje: razvoj vizualizacije, upodabljanja, orodij in tehnologij za odkrivanje in analizo na področju biomedicinskih raziskav, napovedovanja, diagnosticiranja, spremljanja in prognosticiranja bolezni ter v podporo terapevtskim posegom in za njihovo vodenje.
Detection, diagnosis and monitoring: to develop visualisation, imaging, detection and analytical tools and technologies for biomedical research, for prediction, diagnosis, monitoring and prognosis of diseases, and for support and guidance of therapeutic interventions.
Poudarek bo na multidisciplinarnem pristopu, ki vključuje področja, kot so: molekularna in celična biologija, fiziologija, genetika, fizika, kemija, nanotehnologije, mikrosistemi, naprave in informacijske tehnologije.
The focus will be on a multidisciplinary approach integrating areas such as: molecular and cellular biology, physiology, genetics, physics, chemistry, nanotechnologies, microsystems, devices and information technologies.
Poudarjeni bodo neinvazivne ali minimalno invazivne in kvantitativne metode ter vidiki zagotavljanja kakovosti.
Non- or minimally- invasive and quantitative methods and quality assurance aspects will be emphasised.
Poudarek bo na multidisciplinarnem pristopu
The focus will be on a multidisciplinary approach
, pri čemer bo prednost dana diagnostičnim orodjem, neposredno povezanim s terapijo,
, with priority given to diagnostic tools that are directly linked to therapy,
ki vključuje področja, kot so: molekularna in celična biologija, fiziologija, genetika, fizika, kemija, nanotehnologije, mikrosistemi, naprave in informacijske tehnologije.
integrating areas such as: molecular and cellular biology, physiology, genetics, physics, chemistry, nanotechnologies, microsystems, devices and information technologies.
Poudarjeni bodo neinvazivne ali minimalno invazivne in kvantitativne metode ter vidiki zagotavljanja kakovosti.
Non- or minimally-invasive and quantitative methods and quality assurance aspects will be emphasised.
Sprememba 48 Priloga I, del "Teme", oddelek 1 ("Zdravje"), pododdelek "Dejavnosti", naslov 1 ("Biotehnologija, generična orodja in tehnologije za človekovo zdravje"), alinea 4 –
Amendment 48 Annex I, part "Themes", section 1 ("Health"), subsection "Activities", heading 1 ("Biotechnology, generic tools and technologies for human health"), indent 4 –
Predvidevanje primernosti, varnosti in učinkovitosti terapij: razvoj in potrjevanje parametrov, orodij, metod in standardov, potrebnih za oskrbo pacientov z varnimi in učinkovitimi novimi bio zdravili (glede konvencionalnih zdravil bodo ta vprašanja obravnavana v okviru predlagane skupne tehnološke pobude za inovativna zdravila).
Predicting suitability, safety and efficacy of therapies: to develop and validate the parameters, tools, methods and standards needed for bringing to the patient safe and effective new biomedicines [for conventional medicines, these issues will be addressed through the proposed Joint Technology Initiative on Innovative Medicines].
Poudarek bo na pristopih, kot so farmakogenomika, metode in modeli in silico, in vitro (vključno z alternativami za preskuse na živalih) ter in vivo
The focus will be on approaches such as pharmacogenomics, in silico, in vitro (including alternatives to animal testing) and in vivo methods and models
ter spremljanje odpornosti
and immune monitoring
Sprememba 49 Priloga I, del "Teme", oddelek 1 ("Zdravje"), pododdelek "Dejavnosti", naslov 2 ("Translacijske raziskave, ki služijo človekovemu zdravju"), podnaslov 1, zaporedna točka 1
Amendment 49 Annex I, part "Themes", section 1 ("Health"), subsection "Activities", heading 2 ("Translating research for human health"), subheading 1, bullet 1
Zbiranje obsežnejših podatkov: uporaba zahtevnih proizvodnih tehnologij pri zbiranju podatkov za pojasnjevanje funkcije genov in genskih proizvodov ter
Large scale data gathering: to use high-throughput technologies to generate data for elucidating the function of genes, gene products and
celičnih sistemov,
cell systems,
njihovih interakcij v kompleksnih mrežah
their interactions in complex networks
in pomembnih bioloških procesih (tj. sinaptična in celična reorganizacija) ter procesih mutacije
and in important biological processes (i.e. synaptic and cellular reorganisation) and mutation processes
Poudarek bo na: genomiki,
The focus will be on: genomics
vključno z RNK
, including RNA
; proteomiki; populacijski genetiki; primerjalni in funkcionalni genomiki.
; proteomics; population genetics; comparative and functional genomics.
Sprememba 50 Priloga I, del "Teme", oddelek 1 ("Zdravje"), pododdelek "Dejavnosti", naslov 2 ("Translacijske raziskave, ki služijo človekovemu zdravju"), podnaslov 2, zaporedna točka 1
Amendment 50 Annex I, part 'Themes', section 1 ('Health'), subsection 'Activities', heading 2 ('Translating research for human health'), subheading 2, bullet 1
Možgani in z njimi povezane bolezni: boljše razumevanje integrirane strukture in dinamike možganov, proučevanje možganskih bolezni,
Brain and brain-related diseases: to better understand the integrated structure and dynamics of the brain, and to study brain diseases
vključno z vidiki, ki temeljijo na spolu, in pomembnih bolezni, povezanih s staranjem (kot na primer demence, Alzheimerjeve in Parkinsonove bolezni)
, including gender-based aspects, and relevant diseases related to ageing (such as dementia, Alzheimer's or Parkinson's disease)
ter iskanje novih terapij.
and search for new therapies.
Poudarek bo na raziskovanju delovanja možganov od molekul do zaznavanja,
The focus will be to explore brain functions, from molecules to cognition,
možganskih motenj od sinaptične dejavnosti do nevrodegeneracije, in pridobivanje celostnega razumevanja možganov.
and brain dysfunction, from synaptic activity to neurodegeneration, as well as to gain a global understanding of the brain.
Raziskava bo
Research will
in tehnologijami.
and technologies.
Sprememba 51 Priloga I, del "Teme", oddelek 1 ("Zdravje"), pododdelek "Dejavnosti", naslov 2 ("Translacijske raziskave, ki služijo človekovemu zdravju"), podnaslov 2, zaporedna točka 2
Amendment 51 Annex I, part "Themes", section 1 ("Health"), subsection "Activities", heading 2 ("Translating research for human health"), subheading 2, bullet 2
Poudarek bo na proučevanju človeškega sistema in sistema modelov
The focus will be on the study of human and model
in celic,
and cell
vključno z medsebojnim vplivanjem z dejavniki, kot so okolje, vedenje,
systems, including interactions with factors such as environment, behaviour
in spol
and gender
za lajšanje vsakdanjih težav v starosti, in od sinaptične dejavnosti do nevrodegeneracije, med drugim z uporabo kliničnih ali predkliničnih pristopov funkcijskega ali molekularnega slikanja.
with the aim of alleviating the problems of daily life in old age, and from synaptic activity to neurodegeneration, using, inter alia, clinical or preclinical functional or molecular imaging approaches
Rak: poudarek bo na etiologiji bolezni; določanju in vrednotenju ciljev zdravil in bioloških označevalcev, ki pomagajo pri preprečevanju, zgodnjem diagnosticiranju in zdravljenju;
Cancer: the focus will be on disease aetiology; identifying and validating drug targets and biological markers that aid in the prevention, early diagnosis and treatment;
ocenjevanju učinkovitosti prognostičnih, diagnostičnih in terapevtskih posegov.
assessing the effectiveness of prognostic, diagnostic and therapeutic interventions.
Rak: poudarek bo na etiologiji bolezni;
Cancer: the focus will be on disease aetiology
epidemioloških raziskavah, novih zdravilih/terapijah in dejavnikih tveganja
, epidemiological research, new medicines/therapies and risk factors
; določanju in vrednotenju
; identifying and validating
okoljskih determinant,
environmental determinants,
ciljev zdravil in bioloških označevalcev, ki pomagajo pri preprečevanju, zgodnjem diagnosticiranju in zdravljenju; ocenjevanju učinkovitosti prognostičnih, diagnostičnih in terapevtskih posegov.
drug targets and biological markers that aid in the prevention, early diagnosis and treatment; assessing the effectiveness of prognostic, diagnostic and therapeutic interventions.
Degenerativne motnje, povezane s starostjo.
Age-related degenerative disorders.
Sprememba 53 Priloga I, del "Teme", oddelek 1 ("Zdravje"), pododdelek "Dejavnosti", naslov 2 ("Translacijske raziskave, ki služijo človekovemu zdravju"), podnaslov 4, zaporedna točka 3
Amendment 53 Annex I, part "Themes", section 1 ("Health"), subsection "Activities", heading 2 ("Translating research for human health"), subheading 4, bullet 3
Diabetes in debelost: pri prvem bo poudarek na etiologiji različnih vrst diabetesa in s tem povezanega preprečevanja in zdravljenja
Diabetes and obesity: for the former, the focus will be on aetiologies of the different types of diabetes, and their related prevention and treatment
biokemijo in fiziologijo (ocenjeni z uporabo neinvazivnih pristopov, kot sta molekularno in funkcijsko slikanje),
biochemistry and physiology (evaluated using non invasive approaches such as molecular and functional imaging),
življenjskim slogom in epidemiologijo.
life style and epidemiology.
Sprememba 54 Priloga I, del "Teme", oddelek 1 ("Zdravje"), pododdelek "Dejavnosti", podnaslov 2 ("Translacijske raziskave, ki služijo človekovemu zdravju"), podnaslov 4, točka 3 a (novo)
Amendment 54 Annex I, part 'Themes', section 1 ('Health'), subsection 'Activities', second heading ('Translating research for human health'), subheading 4, bullet 3 a (new)
Revmatične bolezni: poudarek bo na etiologiji, zgodnjem diagnosticiranju in bioloških označevalcih za revmatične bolezni in zdravljenju, s posebnim poudarkom na vnetnih revmatičnih boleznih.
Rheumatic diseases: the focus will be on aetiology, early diagnosis and biological markers for rheumatic diseases and treatment, with particular emphasis on inflammatory rheumatic diseases.
Sprememba 55 Priloga I, del "Teme", oddelek 1 ("Zdravje"), pododdelek "Dejavnosti", naslov 2 ("Translacijske raziskave, ki služijo človekovemu zdravju"), podnaslov 4, zaporedna točka 5
Amendment 55 Annex I, part "Themes", section 1 ("Health"), subsection "Activities", heading 2 ("Translating research for human health"), subheading 4, bullet 5
Druge kronične bolezni: poudarek bo na nesmrtonosnih boleznih z močnim učinkom na kakovost življenja v starosti, kot so slabšanje funkcionalnih in senzoričnih sposobnosti ter druge kronične
Other chronic diseases: the focus will be on non-lethal diseases with a high impact on the quality of life at old age such as functional and sensory impairment and other chronic diseases,
, kot so revmatični artritis, osteoporoza, demenca in nevrodegenerativne bolezni
such as rheumatoid arthritis, osteoporosis, dementia and neurodegenerative diseases
Sprememba 56 Priloga I, del "Teme", oddelek 1 ("Zdravje"), pododdelek "Dejavnosti", naslov 2 ("Translacijske raziskave, ki služijo človekovemu zdravju"), podnaslov 4, zaporedna točka 5 a (novo)
Amendment 56 Annex I, part "Themes", section 1 ("Health"), subsection "Activities", heading 2 ("Translating research for human health"), subheading 4, bullet 5 a (new)
Druge bolezni: pozornost bo na boleznih dihal, zapostavljenih boleznih in študijah, ki temeljijo na prebivalstvu, za raziskovanje nastajajočih dejavnikov tveganja.
Other diseases: the focus will be on respiratory diseases, neglected diseases and population-based studies to investigate emerging risk factors.
Sprememba 57 Priloga I, del "Teme", oddelek 1 ("Zdravje"), pododdelek "Dejavnosti", naslov 2 ("Translacijske raziskave, ki služijo človekovemu zdravju"), podnaslov 4, zaporedna točka 5 b (novo)
Amendment 57 Annex I, part "Themes", section 1 ("Health"), subsection "Activities", heading 2 ("Translating research for human health"), subheading 4, bullet 5 b (new)
Sprememba 58 Priloga I, del "Teme", oddelek 1 ("Zdravje"), pododdelek "Dejavnosti", naslov 3 ("Optimalizacija zdravstvenega varstva evropskih državljanov"), alinea 1 –
Amendment 58 Annex I, part 'Themes', section 1 ('Health'), subsection 'Activities', heading 3 ('Optimising the delivery of health care to European citizens'), indent 1 -
Boljše spodbujanje zdravja in preprečevanje bolezni: zagotovitev dokazov za najboljše ukrepe na področju javnega zdravja v smislu življenjskega sloga in intervencij na različnih ravneh in v različnih kontekstih.
Enhanced health promotion and disease prevention: to provide evidence for the best public health measures in terms of life styles and interventions at different levels and in different contexts.
Poudarek bo na širših determinantah zdravja in na njihovem vzajemnem delovanju tako na individualni ravni kot tudi na ravni Skupnosti (npr. prehrana, stres, tobak in druge snovi, fizična aktivnost,
Focus will be on the wider determinants of health and how they interact at both the individual and community level (e.g. diet, stress, tobacco and other substances, physical activity,
kakovost življenja,
the quality of life,
kulturno ozadje, socialno-ekonomski,
cultural context, socio-economic
in okoljski dejavniki).
and environmental factors).
Sprememba 59 Priloga I, del "Teme", oddelek 1 ("Zdravje"), pododdelek "Dejavnosti", naslov 3 ("Optimalizacija zdravstvenega varstva evropskih državljanov"), alinea 2 –
Amendment 59 Annex I, part 'Themes', section 1 ('Health'), subsection 'Activities', heading 3 ('Optimising the delivery of health care to European citizens'), indent 2 -
Prenos kliničnih raziskav v klinično prakso vključno z boljšo uporabo zdravil ter ustrezno uporabo vedenjskih
Translating clinical research into clinical practice including better use of medicines, and appropriate use of behavioural
organizacijskih intervencij ter terapij in tehnologij zdravljenja.
organisational interventions and health therapies and technologies.
kliničnih raziskav v klinično prakso vključno z boljšo uporabo zdravil
clinical research into clinical practice including better use of medicines
(npr. za preprečevanje razvoja odpornosti na antibiotike),
(e.g. with a view to avoiding the development of antibiotic resistance)
ter ustrezno uporabo vedenjskih
, and appropriate use of behavioural
ter intervencij v sisteme javnega zdravstva
and public health system
ter terapij in tehnologij zdravljenja.
interventions and health therapies and technologies.
Posebna pozornost bo namenjena varnosti pacientov
Special attention will be given to patient safety
, vključno s stranskimi učinki zdravil;
, including the side-effects of medicines
ugotavljanje najboljše klinične prakse; razumevanje kliničnega odločanja v okviru osnovne in specializirane oskrbe; ter pospeševanje uporabe z dokazi podprte medicine in dajanja pooblastil pacientom
; to identify the best clinical practice; to understand decision making in clinical settings in primary and specialised care; and to foster applications of evidence-based medicine and patient empowerment
, s čimer se okrepi osebna in socialna neodvisnost pacientov.
with a view to enhancing patients' personal and social autonomy
in novimi zdravstvenimi tehnologijami
and new health technologies
, ob upoštevanju dokazov farmakovigilance, posebnih značilnosti pacienta (npr. genska odpornost, starost, spol in privrženost načelom) ter stroškovnih ugodnosti
, taking into consideration pharmacovigilance evidence, specificities of the patient (e.g. genetic susceptibility, age, gender and adherence) and cost benefits
v zvezi z zdravjem, kakovostjo življenja in dobro prakso
in terms of health, quality of life and good practice
Sprememba 60 Priloga I, del "Teme", oddelek 1 ("Zdravje"), pododdelek "Dejavnosti", naslov 3 ("Optimalizacija zdravstvenega varstva evropskih državljanov"), alinea 3 –
Amendment 60 Annex I, part "Themes", section 1 ("Health"), subsection "Activities", heading 3 ("Optimising the delivery of health care to European citizens"), indent 3 –
Kakovost, solidarnost in trajnost zdravstvenih sistemov; državam zagotoviti osnovo za prilagajanje njihovih zdravstvenih sistemov glede na izkušnje drugih ob upoštevanju pomembnosti nacionalnega ozadja in značilnosti prebivalstva (staranje, mobilnost, migracije, izobraževanje, socialno-ekonomski položaj, spreminjajoč se svet dela itd.).
Quality, solidarity and sustainability of health systems; to provide a basis for countries to adapt their health systems in the light of experience of others, taking into account the importance of national contexts and population characteristics (ageing, mobility, migration, education, socioeconomic status and the changing world of work etc).
Posebna pozornost bo namenjena vprašanju naložb in človeškim virom
Special attention will be paid to investment issues and human resources and
Ustrezna uporaba novih tehnologij in terapij.
Appropriate use of new technologies and therapies.
62 Priloga I, del "Teme", oddelek 2 ("Prehrana, kmetijstvo in biotehnologija"), pododdelek "Pristop", odstavek 2
62 Annex I, part "Themes", section 2 ("Food, Agriculture and Biotechnology"), subsection "Approach", paragraph 2
Namen raziskav biološke raznovrstnosti in njenih molekularnih značilnosti je, da se jo zaščiti, ne pa zgolj odkrivanje novih načinov za njeno izkoriščanje.
Investigating biodiversity and its molecular characterisation is aimed at its protection, not only at identifying new ways for its exploitation.
Treba bi si bilo prizadevati za povezovanje s temo "Okolje".
Integration with the "Environment" theme should be sought.
Sprememba 64 Priloga I, del "Teme", oddelek 2 ("Prehrana, kmetijstvo in biotehnologija"), pododdelek "Dejavnosti", naslov 1 ("Trajnostna proizvodnja in gospodarjenje ..."), alinea 2 –
Amendment 64 Annex I, part 'Themes', section 2 ('Food, Agriculture and Biotechnology'), subsection 'Activities', heading 1 ('Sustainable production and management of ...'), indent 2 -
Povečana trajnost in konkurenčnost ob zmanjšanju okoljskih vplivov v kmetijstvu, gozdarstvu, ribištvu in ribogojstvu z razvojem novih tehnologij, opreme, nadzornih sistemov, novih rastlin in proizvodnih sistemov, izboljšanje znanstvene in tehnične osnove upravljanja ribištva ter boljše razumevanje medsebojnega delovanja različnih sistemov (kmetijstvo in gozdarstvo; ribištvo in ribogojstvo) v okviru pristopa celostnega obravnavanja ekosistemov.
Increased sustainability and competitiveness, while decreasing environmental impacts, in agriculture, forestry, fisheries and aquaculture through the development of new technologies, equipment, monitoring systems, novel plants and production systems, the improvement of the scientific and technical basis of fisheries management, and a better understanding of the interaction between different systems (agriculture and forestry; fisheries and aquaculture) across a whole ecosystem approach.
z viri, novo krmo in novimi rastlinami (pridelki in drevesa) z izboljšano sestavo, odpornostjo na stres, učinkovitostjo rabe hranil in strukturo.
management of resources and novel feeds, and novel plants (crops and trees) with improved composition, resistance to stress, nutrient use efficiency, and architecture.
Povečana trajnost in konkurenčnost ob
Increased sustainability and competitiveness, while
varstvu zdravja potrošnikov in
safeguarding consumer health and
zmanjšanju okoljskih vplivov v kmetijstvu, gozdarstvu, ribištvu in ribogojstvu z razvojem novih tehnologij, opreme, nadzornih sistemov, novih rastlin in proizvodnih sistemov, izboljšanje znanstvene in tehnične osnove upravljanja ribištva
decreasing environmental impacts, in agriculture, forestry, fisheries and aquaculture through the development of new technologies, equipment, monitoring systems, novel plants and production systems, the improvement of the scientific and technical basis of fisheries
, ter boljše razumevanje medsebojnega delovanja različnih sistemov (kmetijstvo in gozdarstvo; ribištvo in ribogojstvo) v okviru pristopa celostnega obravnavanja ekosistemov.
, and a better understanding of the interaction between different systems (agriculture and forestry; fisheries and aquaculture) across a whole ecosystem approach.
Pri zemeljskih bioloških virih bo poseben poudarek na nizkih vložkih in organskih proizvodnih sistemih
For land based biological resources, special emphasis will be placed on low input and organic production systems,
Zdravje rastlin
Plant health
in zaščita pridelkov
and crop protection
in plevela.
management tools and techniques.
Sprememba 65 Priloga I, del "Teme", oddelek 2 ("Prehrana, kmetijstvo in biotehnologija"), pododdelek "Dejavnosti", naslov 1 ("Trajnostna proizvodnja in gospodarjenje ..."), alinea 3 –
Amendment 65 Annex I, part 'Themes', section 2 ('Food, Agriculture and Biotechnology'), subsection 'Activities', heading 1 ('Sustainable production and management of ...'), indent 3 -
, njihovimi patogenimi mehanizmi in boleznimi, povezanimi z živalsko krmo
and their pathogenic mechanisms and diseases linked to animal feed